-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$403.92-21.83% Downside
Recent Analyst Forecasts and Stock Ratings
Vertex Pharmaceuticals Incorporated Frequently Asked Questions
-
What analysts cover Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated has been rated by research analysts at Oppenheimer, RBC Capital, Canaccord Genuity, BMO Capital, Goldman Sachs, Bank of America Securities in the past 90 days.